Smith Group Asset Management, LLC
- SEC CIK
- 0001893134
- Latest filing
- Aug 3, 2026
RDY holding history
Dr Reddys Laboratories Ltd in every 13F filed by Smith Group Asset Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
RDY overviewAll 13F holders of RDYFull Q2 2026 holdings
- Shares (Q3 2025)
- 0
- Sold out in Q3 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 6
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2025 | 0 | $0 | 0.0% | −58,430−100.0% | Sold out | Holders |
| Q2 2025 | 58,430 | $878.2K | 0.1% | +15,430+35.9% | Added | Holders |
| Q1 2025 | 43,000 | $567.2K | <0.1% | −400−0.9% | Reduced | Holders |
| Q4 2024 | 43,400 | $685.3K | 0.1% | +43,400 | New | Holders |
| Q2 2022 | – | – | – | – | Not filed | Holders |
| Q1 2022 | 11,290 | $629.0K | <0.1% | −100−0.9% | Reduced | Holders |
| Q4 2021 | 11,390 | $745.0K | <0.1% | −300−2.6% | Reduced | Holders |
| Q3 2021 | 11,690 | $761.0K | <0.1% | – | No prior filing | Holders |